Clinical Research Directory

Inclusion Criteria: * Patients with uterine cancer (including endometrial and uterine carcinoma or sarcoma) treated with surgery +/- radiation at MD Anderson between 2006 and 2017 * Eligible surgeries include laparoscopic or robotic assisted abdominal total hysterectomy, total abdominal hysterectomy, and vaginal hysterectomy with or without pelvic node dissection, with or without omentectomy or omental biopsies * In addition, patients must have had all WITH bilateral-salpingo-oophorectomy (BSO), either during their surgery or in a previous or subsequent (within 3 months of endometrial cancer diagnosis) surgery * Patients have had at least one year of follow-up * Patients have not had any recurrence of disease * Patients must be able to complete the survey of their own volition * Patients must be able to read and speak English fluently * CONTROL GROUP: Patients have never been diagnosed with any cancer other than non-melanomatous skin cancers * CONTROL GROUP: Patient has undergone hysterectomy/BSO for benign reasons between 2006 and 2017 * CONTROL GROUP: Patients must be able to complete the survey of their own volition * CONTROL GROUP: Patients must be able to speak and read English fluently Exclusion Criteria: * Patients with cancer recurrence, as this will affect their current quality of life * Patients with additional pelvic surgery at the time of their hysterectomy (for example pelvic exenteration, urostomy placement, etc.) * Patients with a secondary primary cancer (including cervical cancer), as this will affect their current quality of life. Patients may have either squamous cell or basal cell carcinoma of the skin * Neurocognitive deficits that render patients unable to complete the survey on their own * Patients who have not yet had removal of their bilateral ovaries * Preoperative radiotherapy prior to hysterectomy